Related Experiment Video
Updated: Jul 8, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
The topographical distribution of tissue injury in benign MS: a 3T multiparametric MRI study
Antonia Ceccarelli1, Maria A Rocca, Elisabetta Pagani
1Neuroimaging Research Unit, Scientific Institute and University Ospedale San Raffaele, Milan, Italy.
Abstract:
We compared the global and regional distribution of white matter (WM) and gray matter (GM) damage and T2-visible lesion between patients with benign (B) and relapsing remitting (RR) multiple sclerosis (MS). BMS and RRMS patients did not differ in terms of global volumes and diffusion tensor (DT) MRI metrics of the WM and GM. Compared to controls, BMS and RRMS patients had bilateral thalamic loss. Compared to controls, BMS and RRMS patients had lower WM fractional anisotropy (FA) in the corpus callosum (CC) and in several regions of temporal and occipital lobes. BMS also had a decreased WM FA in the parietal lobes. RRMS patients had also lower WM FA in several regions of the frontal lobes. Compared to BMS, RRMS patients had decreased WM FA in the frontal lobes, while the opposite comparison showed lower WM FA in the CC, the temporal lobes and the cuneus in BMS. Contrasted to controls, both MS groups showed several regions of increased MD in WM and GM, but no difference was found between MS sub-groups. T2-visible lesions were mainly located in the posterior regions of the brain in BMS patients, while they involved also regions in the frontal lobes, in RRMS patients. BMS and RRMS patients differ in terms of the topographical distribution of WM damage rather than in the overall extent of brain structural changes. The less prominent involvement of the frontal lobe WM and of the NAWM in general in BMS might be associated to their favorable clinical status.
Insights
Benign multiple sclerosis (MS) and relapsing-remitting MS (RRMS) patients show similar brain damage extent but differ in white matter lesion distribution. Benign MS primarily affects posterior brain regions, unlike RRMS.
Area of Science:
- Neuroimaging
- Neurology
- Radiology
Background:
- Multiple Sclerosis (MS) is a chronic neurological disease.
- Distinguishing between benign MS (BMS) and relapsing-remitting MS (RRMS) is crucial for prognosis and treatment.
- Understanding the topographical distribution of brain damage in different MS subtypes is essential.
Purpose of the Study:
- To compare the global and regional distribution of white matter (WM) and gray matter (GM) damage between BMS and RRMS patients.
- To investigate differences in T2-visible lesion location between BMS and RRMS.
- To correlate brain structural changes with clinical status.
Main Methods:
- Diffusion Tensor (DT) MRI and T2-visible lesion mapping were used.
- Global and regional WM and GM volumes and metrics were analyzed.
- Comparisons were made between BMS patients, RRMS patients, and healthy controls.
Main Results:
- BMS and RRMS patients showed no significant differences in global brain volumes or overall DT-MRI metrics.
- Both MS groups exhibited bilateral thalamic loss and reduced WM fractional anisotropy (FA) in specific brain regions compared to controls.
- T2-lesion distribution differed, with BMS showing posterior lesions and RRMS involving frontal lobe regions.
Conclusions:
- BMS and RRMS patients differ in the topographical distribution of WM damage, not the overall extent of brain structural changes.
- The less pronounced frontal lobe WM involvement in BMS may correlate with their favorable clinical status.
- These findings highlight the importance of lesion location in understanding MS subtypes.
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies IV: Magnetic Resonance Imaging

